Lv2
170 积分 2024-04-08 加入
Advances in systemic therapies for triple negative breast cancer
14天前
已完结
HSP70 promotes tumor progression by stabilizing Skp2 expression in gastric cancer cells
1个月前
已完结
Clinical progress and functional modalities of HDAC inhibitor-based combination therapies in cancer treatment
1个月前
已完结
Strategies for targeting undruggable targets
2个月前
已完结
Chasing molecular glue degraders: screening approaches
2个月前
已完结
Discovery of CRBN-dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library
2个月前
已完结
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer
2个月前
已完结
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
2个月前
已完结
Identification of an allosteric site on the E3 ligase adapter cereblon
3个月前
已完结
The complex universe of inactive PARP1
4个月前
已完结
皖公网安备34019202002308
